Top Key Companies for Biomarker Technology Market: Abbott Laboratories, Quanterix, Bio-Rad Laboratories, Epigenomics, Agilent Technologies, Johnson & Johnson, Qiagen, Roche Holding, Siemens Healthcare, Myriad Genetics.
Global Biomarker Technology Market Size was estimated at USD 5448.49 million in 2022 and is projected to reach USD 21035 million by 2028, exhibiting a CAGR of 25.25% during the forecast period.
Global Biomarker Technology Market Overview And Scope:
The Global Biomarker Technology Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Biomarker Technology utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Biomarker Technology Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biomarker Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biomarker Technology market.
Global Biomarker Technology Market Segmentation
By Type, Biomarker Technology market has been segmented into:
Polymerase Chain Reaction(PCR)
Next Generation Sequencing(NGS)
Immunoassay
Others
By Application, Biomarker Technology market has been segmented into:
Cancer
Infectious Diseases
Auoimmune Disorders
Cardiovascular Disorders
Others
Regional Analysis of Biomarker Technology Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Biomarker Technology Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biomarker Technology market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Biomarker Technology market.
Top Key Companies Covered in Biomarker Technology market are:
Abbott Laboratories
Quanterix
Bio-Rad Laboratories
Epigenomics
Agilent Technologies
Johnson & Johnson
Qiagen
Roche Holding
Siemens Healthcare
Myriad Genetics
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Biomarker Technology Market by Type
5.1 Biomarker Technology Market Overview Snapshot and Growth Engine
5.2 Biomarker Technology Market Overview
5.3 Polymerase Chain Reaction(PCR)
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Polymerase Chain Reaction(PCR): Geographic Segmentation
5.4 Next Generation Sequencing(NGS)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Next Generation Sequencing(NGS): Geographic Segmentation
5.5 Immunoassay
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Immunoassay: Geographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation
Chapter 6: Biomarker Technology Market by Application
6.1 Biomarker Technology Market Overview Snapshot and Growth Engine
6.2 Biomarker Technology Market Overview
6.3 Cancer
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Cancer: Geographic Segmentation
6.4 Infectious Diseases
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Infectious Diseases: Geographic Segmentation
6.5 Auoimmune Disorders
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Auoimmune Disorders: Geographic Segmentation
6.6 Cardiovascular Disorders
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Cardiovascular Disorders: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2026-2035F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Biomarker Technology Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Biomarker Technology Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Biomarker Technology Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBOTT LABORATORIES
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 QUANTERIX
7.4 BIO-RAD LABORATORIES
7.5 EPIGENOMICS
7.6 AGILENT TECHNOLOGIES
7.7 JOHNSON & JOHNSON
7.8 QIAGEN
7.9 ROCHE HOLDING
7.10 SIEMENS HEALTHCARE
7.11 MYRIAD GENETICS
Chapter 8: Global Biomarker Technology Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Polymerase Chain Reaction(PCR)
8.2.2 Next Generation Sequencing(NGS)
8.2.3 Immunoassay
8.2.4 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Cancer
8.3.2 Infectious Diseases
8.3.3 Auoimmune Disorders
8.3.4 Cardiovascular Disorders
8.3.5 Others
Chapter 9: North America Biomarker Technology Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Polymerase Chain Reaction(PCR)
9.4.2 Next Generation Sequencing(NGS)
9.4.3 Immunoassay
9.4.4 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Cancer
9.5.2 Infectious Diseases
9.5.3 Auoimmune Disorders
9.5.4 Cardiovascular Disorders
9.5.5 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Biomarker Technology Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Polymerase Chain Reaction(PCR)
10.4.2 Next Generation Sequencing(NGS)
10.4.3 Immunoassay
10.4.4 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Cancer
10.5.2 Infectious Diseases
10.5.3 Auoimmune Disorders
10.5.4 Cardiovascular Disorders
10.5.5 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Biomarker Technology Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Polymerase Chain Reaction(PCR)
11.4.2 Next Generation Sequencing(NGS)
11.4.3 Immunoassay
11.4.4 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Cancer
11.5.2 Infectious Diseases
11.5.3 Auoimmune Disorders
11.5.4 Cardiovascular Disorders
11.5.5 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Biomarker Technology Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Polymerase Chain Reaction(PCR)
12.4.2 Next Generation Sequencing(NGS)
12.4.3 Immunoassay
12.4.4 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Cancer
12.5.2 Infectious Diseases
12.5.3 Auoimmune Disorders
12.5.4 Cardiovascular Disorders
12.5.5 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Biomarker Technology Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Polymerase Chain Reaction(PCR)
13.4.2 Next Generation Sequencing(NGS)
13.4.3 Immunoassay
13.4.4 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Cancer
13.5.2 Infectious Diseases
13.5.3 Auoimmune Disorders
13.5.4 Cardiovascular Disorders
13.5.5 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Biomarker Technology Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Polymerase Chain Reaction(PCR)
14.4.2 Next Generation Sequencing(NGS)
14.4.3 Immunoassay
14.4.4 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Cancer
14.5.2 Infectious Diseases
14.5.3 Auoimmune Disorders
14.5.4 Cardiovascular Disorders
14.5.5 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Biomarker Technology Scope:
|
Report Data
|
Biomarker Technology Market
|
|
Biomarker Technology Market Size in 2025
|
USD XX million
|
|
Biomarker Technology CAGR 2025 - 2032
|
XX%
|
|
Biomarker Technology Base Year
|
2024
|
|
Biomarker Technology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Quanterix, Bio-Rad Laboratories, Epigenomics, Agilent Technologies, Johnson & Johnson, Qiagen, Roche Holding, Siemens Healthcare, Myriad Genetics.
|
|
Key Segments
|
By Type
Polymerase Chain Reaction(PCR)
Next Generation Sequencing(NGS)
Immunoassay
Others
By Applications
Cancer
Infectious Diseases
Auoimmune Disorders
Cardiovascular Disorders
Others
|
